← OMEGA HEALTHCARE INVESTORS INC OHI
Market Price
$46.52
Market Cap
$13.70B
P/E Ratio
23.98
Revenue (FY 2025)
↑13.2% YoY
$1.19B
3-Yr CAGR: 10.7%
Net Income
↑45.2% YoY
$590.18M
Net Margin: 49.6%
Free Cash Flow
↑12.1% YoY
$797.68M
FCF Yield: 5.82%
EPS (Diluted)
↑25.2% YoY
$1.94
Basic: $1.96
Return on Equity
Efficiency
11.4%
ROA: 5.9%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (OHI)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $900.8M | — | $736.7M | $366.4M | — | $1.90 | — | $625.8M | $585.3M | — |
| FY 2017 | $908.4M | +0.8% | $719.6M | $100.4M | -72.6% | $0.51 | -73.2% | $577.9M | $540.1M | -7.7% |
| FY 2018 | $881.7M | -2.9% | $689.2M | $281.6M | +180.4% | $1.40 | +174.5% | $499.4M | $469.5M | -13.1% |
| FY 2019 | $928.8M | +5.3% | $729.7M | $0.0M | -100.0% | $1.58 | +12.9% | $553.7M | $500.9M | +6.7% |
| FY 2020 | $892.4M | -3.9% | $669.0M | $159.3M | +10,083,987,241.8% | $0.70 | -55.7% | $708.3M | $677.2M | +35.2% |
| FY 2021 | $1,062.8M | +19.1% | $828.2M | $416.7M | +161.6% | $1.75 | +150.0% | $722.1M | $721.4M | +6.5% |
| FY 2022 | $878.2M | -17.4% | $645.0M | $426.9M | +2.4% | $1.80 | +2.9% | $625.7M | $625.7M | -13.3% |
| FY 2023 | $949.7M | +8.1% | $714.2M | $242.2M | -43.3% | $1.00 | -44.4% | $617.7M | $617.7M | -1.3% |
| FY 2024 | $1,051.4M | +10.7% | $829.7M | $406.3M | +67.8% | $1.55 | +55.0% | $749.4M | $711.7M | +15.2% |
| FY 2025 | $1,190.1M | +13.2% | $975.1M | $590.2M | +45.2% | $1.94 | +25.2% | $878.6M | $797.7M | +12.1% |
Valuation
Market Price
$46.52
Market Cap
$13.70B
Enterprise Value
$17.93B
P/E Ratio
23.98
P/B Ratio
2.67
FCF Yield
5.82%
Dividend Yield
5.76%
Shares Outstanding
Profitability & Margins
Gross Margin
81.93%
Operating Margin
1.09%
Net Margin
49.59%
Return on Equity (ROE)
11.39%
Return on Assets (ROA)
5.87%
Asset Turnover
0.12x
Revenue 3-Yr CAGR
10.66%
Financial Health & Liquidity
Current Ratio
N/A
Cash Ratio
N/A
Debt / Equity
0.821
Debt / Assets
0.424
Cash & Equivalents
$27.02M
Total Debt
$4.26B
Book Value / Share
$17.40
Cash Flow Efficiency
Operating Cash Flow
$878.55M
Capital Expenditures (CapEx)
$80.87M
Free Cash Flow
$797.68M
OCF / Revenue
73.82%
FCF / Revenue
67.03%
FCF 3-Yr CAGR
8.43%
Per Share Metrics
EPS (Diluted)
$1.94
EPS (Basic)
$1.96
Dividends / Share
$2.68
Book Value / Share
$17.40
EPS YoY Growth
25.16%
Balance Sheet (FY 2025)
Total Assets
$10.05B
Total Liabilities
$4.61B
Stockholders' Equity
$5.18B
Current Assets
N/A
Current Liabilities
N/A